BE837709A - Procede de preparation d'antigene d'hepatite b purifiee et produits obtenus - Google Patents

Procede de preparation d'antigene d'hepatite b purifiee et produits obtenus

Info

Publication number
BE837709A
BE837709A BE163625A BE163625A BE837709A BE 837709 A BE837709 A BE 837709A BE 163625 A BE163625 A BE 163625A BE 163625 A BE163625 A BE 163625A BE 837709 A BE837709 A BE 837709A
Authority
BE
Belgium
Prior art keywords
antigen
preparation
products obtained
purified hepatitis
hepatitis
Prior art date
Application number
BE163625A
Other languages
English (en)
Inventor
J Vnek
A M Prince
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE837709A publication Critical patent/BE837709A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE163625A 1973-12-20 1976-01-20 Procede de preparation d'antigene d'hepatite b purifiee et produits obtenus BE837709A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/426,825 US3951937A (en) 1973-12-20 1973-12-20 Large scale purification of hepatitis type B antigen using polyethylene glycol

Publications (1)

Publication Number Publication Date
BE837709A true BE837709A (fr) 1976-05-14

Family

ID=23692350

Family Applications (1)

Application Number Title Priority Date Filing Date
BE163625A BE837709A (fr) 1973-12-20 1976-01-20 Procede de preparation d'antigene d'hepatite b purifiee et produits obtenus

Country Status (2)

Country Link
US (1) US3951937A (fr)
BE (1) BE837709A (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2303562A1 (fr) * 1975-03-14 1976-10-08 Community Blood Council Greate Nouvelle preparation d'antigene utilisable comme vaccin
US4086218A (en) * 1975-04-11 1978-04-25 Edward Shanbrom, Inc. Method of preserving blood plasma II
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
US4174388A (en) * 1977-02-14 1979-11-13 Merck & Co., Inc. Method for preparing hepatitis B immune globulin
US4197238A (en) * 1977-04-12 1980-04-08 The Green Cross Corporation Method of preparation of human albumin using polyethylene glycol
US4232004A (en) * 1977-09-21 1980-11-04 American National Red Cross Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen
JPS54101421A (en) * 1978-01-27 1979-08-10 Merck & Co Inc Hepatitis b surface antigen
DE2803920A1 (de) * 1978-01-30 1979-08-02 Merck & Co Inc Verfahren zur gewinnung von hepatitis b-oberflaechenantigen
US4242324A (en) * 1979-04-04 1980-12-30 Merck & Co., Inc. Hepatitis B antigen
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4511473A (en) * 1982-02-09 1985-04-16 Amf Incorporated Fibrous media containing millimicron-sized particulates
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The ＨＢｓＡｇの精製方法
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
US5462863A (en) * 1989-02-09 1995-10-31 Development Center For Biotechnology Isolation of Hepatitis B surface antigen from transformed yeast cells
US5474900A (en) * 1990-03-16 1995-12-12 Sekisui Chemical Co., Ltd. Process for preparing purified syphilis antigen from Treponema palljdum
CN100494362C (zh) * 2001-08-07 2009-06-03 诺维信公司 碳水化合物和多元醇用于溶解蛋白晶体
US20060127974A1 (en) * 2002-07-01 2006-06-15 Novozymes A/S Mpg added to fermentation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US3790552A (en) * 1972-03-16 1974-02-05 Us Health Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol

Also Published As

Publication number Publication date
US3951937A (en) 1976-04-20

Similar Documents

Publication Publication Date Title
BE837709A (fr) Procede de preparation d'antigene d'hepatite b purifiee et produits obtenus
BE823425A (fr) Procede pour la preparation d'alpha-acyloxycetones et d'alpha-acyloxyaldehydes et produits obtenus
FR2279720A1 (fr) Procede de preparation d'alkyltetracyclines et nouveaux produits obtenus
BE750797A (fr) Procede de preparation d'acylimidazoles et produits obtenus
BE832663A (fr) Procede perfectionne de preparation de thiourees et de guanidines et produits obtenus
FR2306214A1 (fr) Procede de preparation de 17 a-ester-21-halopregnanes et nouveaux produits ainsi obtenus
BE838147A (fr) Procede pour la preparation d'acides alkylsulfoniques et produits obtenus
BE832664A (fr) Procede perfectionne de preparation de cyanoghanidines et produits obtenus
FR2274299A1 (fr) Procede de preparation de 7b-acylamino-7a-alcoxycephalosporines et 6b-acylamino-6a-alcoxy-penicillines, nouveaux produits obtenus et leur application
FR2348936A1 (fr) Procede de preparation de copolymeres de l'acrylonitrile et produits obtenus
BE807556A (fr) Procede de preparation de n1-(2'-furannidyle)-uraciles et de n1-(2'-pyrannidyle)-uraciles et produits obtenus
BE817761A (fr) Procede de preparation d'o-benzyltoluenes
FR2328692A1 (fr) Procede pour la preparation d'alpha, omega-diamines aliphatiques, et produits obtenus
BE817961A (fr) Procede pour la preparation de graphite de purete nucleaire et produits obtenus
OA05233A (fr) Procédé de préparation d'acides (7-acétamido Disubstitue)-3- substitue-3- cephem-4-carboxyliques et nouveaux produits industriels.
BE832662A (fr) Procede perfectionne de preparation de thiourees et produits obtenus
BE769324A (fr) Procede de preparation d'alcoylidenenorbornenes et produits obtenus
BE790466A (fr) Procede de preparation d'aminopenicillines et produits ainsi obtenus
BE823526A (fr) Procede de preparation d'hydroxyethercarboxylates et nouveaux produits ainsi obtenus
CH537406A (fr) Procédé de préparation d'amides de l'acide x-cyanoacrylique
FR2313372A1 (fr) Procede pour la preparation de 2-acylamino-oxazoles et produits obtenus
BE831223A (fr) Procede de preparation de boissons et produits resultants
FR2282416A1 (fr) Procede de preparation de produits d'autocondensation
BE806410A (fr) Procede de preparation d'alkylhydroxybenzenes et produits obtenus
BE823796A (fr) Procede pour la preparation de 2-benzoylpyridines substituees et produits obtenus

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE COMMUNITY BLOOD COUNCIL OF GREAT NEW YORK INC

Effective date: 19870131